GSS 0.00% 72.5¢ genetic signatures limited

Ann: Presenting at Bell potter healthcare conference, page-17

  1. Al.
    198 Posts.
    lightbulb Created with Sketch. 114
    yes i understand there are existing tests but right there you are talking about 5 seperate tests - the stab in the dark type approach - this is more a waste of resources and a lost opportunity for epidemiological data than multiplex;
    screening for eg due to the Syphillus outbreak currently in Victoria is a good expenditure of funds having regard to the cost of lifetime disability from preventable! Birth defects

    @uktion I like your conservative approach to Val & would be more than happy with that

    I’m just conscious to remind myself a previous weak handed investor of the investment case/ conviction, having sold $100k of XRO at circa $21 -only to have it hit $135 4-5 years later


 
watchlist Created with Sketch. Add GSS (ASX) to my watchlist
(20min delay)
Last
72.5¢
Change
0.000(0.00%)
Mkt cap ! $164.4M
Open High Low Value Volume
72.0¢ 72.5¢ 72.0¢ $1.886K 2.601K

Buyers (Bids)

No. Vol. Price($)
4 17462 70.5¢
 

Sellers (Offers)

Price($) Vol. No.
72.0¢ 2 1
View Market Depth
Last trade - 10.55am 10/09/2024 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.